InvestorsHub Logo
Followers 125
Posts 21016
Boards Moderated 0
Alias Born 06/13/2011

Re: Laurent Maldague post# 404836

Saturday, 03/04/2023 1:01:05 PM

Saturday, March 04, 2023 1:01:05 PM

Post# of 428507
Re

IPE clearly has no equal.


So can you show me an independent double blinded Outcome trial run in US CAD patients without a mineral oil placebo ....to support that statement ?
I'm not asking for a whole re run of R-IT ...but maybe 2 yrs of MITIGATE data to match the event line separation at 2 yrs in R-IT
2 yrs of data ....what's that... Sept 2023 ?
AMRN funded this to Feb 28th 2023 ...why not to Sept 2023 ?

MITIGATE was fully enrolled in Sept 2021...and they are tracking CV endpoints .
Why the radio silence on MITIGATE ...which apparently was completed on Feb 28th .
No notice like ...Trial is completed ...Data is locked and results will be released in about _______

How about Real World Data . Kaiser must have enough by now on their secondary prevention CAD patients ?

Now before U all get in a tizzy about this post ....I'm one of the chief beneficiary's of the R-IT numbers the Capt just posted if independently confirmed .
I'm still taking my 4 gms of Vascepa daily and would continue to do so even if the RR was half of what is currently claimed .

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News